Ginsenoside Rh4

Ginsenoside Rh4 (CAS No.: 174721-08-5) is a rare saponin derived from Panax notoginseng, prominent in the biomedical research domain for its potential in drug discovery. As an important constituent of traditional Chinese medicine, ginsenoside Rh4 orchestrates a multitude of biological processes, chiefly by modulating key signaling pathways. Notably, it has been shown to inhibit signaling cascades such as Wnt/β-catenin, JAK2/STAT3, and TGF-β/Smad2/3, thereby impacting various cellular mechanisms. The compound is known to activate pro-apoptotic proteins, including Bax, caspase 3, caspase 8, and caspase 9, while also inducing autophagy, suggesting its role in programmed cell death and maintenance of cellular homeostasis. Ginsenoside Rh4 exhibits cytotoxic properties with efficacy observed in cancer cell lines, demonstrating activity levels in the low micromolar range, which underscores its candidacy for in vitro and potentially animal model studies focused on oncology. While specific concentrations are contingent on experimental parameters, its application in research is versatile, allowing exploration as an adjuvant due to its low or non-haemolytic effects. This compound's evaluation spans various in vitro models, emphasizing its capacity to modulate cell growth and survival pathways, marking it as a valuable tool in the exploration of complex biological systems and drug screening endeavors.